A groundbreaking new blood test for Lyme disease is showing remarkable results, with over 90% accuracy across all disease stages, as presented at the 2025 Association for Diagnostics & Laboratory Medicine meeting.

Currently, diagnosing Lyme disease presents significant challenges; while some patients develop a characteristic rash, about 30% don't show this symptom, making early detection difficult.

LymeSeek is an innovative test that simultaneously detects 10 different antigens and uses deep learning algorithms to analyze responses, delivering unprecedented sensitivity and specificity.

The results are impressive : In very early stages, LymeSeek achieved 100% accuracy compared to just 37% with standard testing. Even in posttreatment cases after 6 months, it identified 97% of cases whi

See Full Page